Concepedia

Publication | Open Access

Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy

73

Citations

37

References

2013

Year

Abstract

NLR may serve as a potential biomarker for survival prognosis in patients with stage III-IV gastric cancer receiving neoadjuvant chemotherapy.

References

YearCitations

Page 1